Insiders · Profile

Patel Kinnari

See Remarks at ROCKET PHARMACEUTICALS. Filing since 6 Dec 2018. CIK 0001725929

Company

Date

Role

Action

Shares

Amount

Of holding

RCKT ROCKET PHARMACEUTICALS, INC.

20 May 2025

See Remarks

Sold at will

767

$4.94K

0.2%

RCKT ROCKET PHARMACEUTICALS, INC.

16 May 2025

See Remarks

Sold at will

1,409

$9.20K

0.3%

RCKT ROCKET PHARMACEUTICALS, INC.

9 Apr 2025

See Remarks

Bought

21,099

$99.17K

372%

RCKT ROCKET PHARMACEUTICALS, INC.

21 Feb 2025

See Remarks

Sold at will

6,078

$64.31K

1.4%

RCKT ROCKET PHARMACEUTICALS, INC.

21 Nov 2024

See Remarks

Sold at will

4,588

$59.89K

1.2%

RCKT ROCKET PHARMACEUTICALS, INC.

16 Aug 2024

See Remarks

Sold at will

3,989

$73.81K

1.0%

RCKT ROCKET PHARMACEUTICALS, INC.

16 May 2024

See Remarks

Sold at will

4,046

$94.47K

1.0%

RCKT ROCKET PHARMACEUTICALS, INC.

16 Feb 2024

See Remarks

Sold at will

7,132

$212.80K

2.9%

RCKT ROCKET PHARMACEUTICALS, INC.

17 Aug 2023

See Remarks

Sold at will

1,534

$23.73K

0.7%

RCKT ROCKET PHARMACEUTICALS, INC.

17 May 2023

See Remarks

Sold at will

1,330

$28.43K

0.6%

RCKT ROCKET PHARMACEUTICALS, INC.

28 Dec 2020

Chief Operating Officer

Sold, plan not stated

16,761

$950.74K

15.0%

RCKT ROCKET PHARMACEUTICALS, INC.

18 Mar 2020

Chief Operating Officer

Bought

1,000

$9.50K

17.6%

RCKT ROCKET PHARMACEUTICALS, INC.

6 Dec 2018

Chief Operating Officer

Bought

5,675

$85.01K

opened

13 decisions on file.